Takeda's dengue vaccine has been authorised for use in the European Union, the Japanese drugmaker said on Thursday.
It is the second vaccine approved by the EU for the mosquito-borne disease which causes millions of infections annually.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
{{#Source}}{{Source}}{{/Source}}{{#IsBlog}}
{{Disclaimer}}
{{/Disclaimer}}